Trial intelligence / Profile preview

Ginger for Chemotherapy-induced Nausea and Vomiting in Breast Cancer

NCT02390648Phase 2Completed

Sponsor
Mahidol University
Start
Mar 2015
Primary completion
Feb 2016
Countries
1
01

Overview

Phase 2, randomised, double-blind trial (2 arms), sponsored by Mahidol University. Primary endpoints: Nausea score at 5 days and Vomiting at 5 days. Started Mar 2015; status: completed.

Beyond the preview

Go deeper on NCT02390648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02390648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call